Ten patients undergoing hip replacement surgery were studied regarding activation of complement and leukocytes in association with collection of wound drainage blood. The blood was collected postoperatively but not reinfused due to the possible risks with reinfusion of blood containing inflammatory mediators. Blood samples for analysis of complement activation (TCC), leukocyte activation (PMN elastase) and cytokines (Interleukin-6) were drawn preoperatively from the patients. Blood samples were also drawn intraoperatively from the wound. Samples were also drawn from the collected wound drainage blood, before and after blood was passed through a microporous filter. There were elevated concentrations of TCC, PMN elastase and IL-6 in the collected wound drainage blood before and after the filter. The filtration did not significantly reduce the concentrations of these factors. In the wound blood the concentrations were higher compared to those found in the systemic blood preoperatively, but lower compared to concentrations found in the collected drainage blood. The study demonstrates that the collection of wound drainage whole blood is associated with activation of complement, release of PMN elastase and cytokines.
DaleRF, LindopMJ, FarmanJV, SmithMF.Autotransfusion: An experience of seventy-six cases. Ann Coll Surg Engl1986; 68:295–297.
3.
ImhoffM, SchmidtR, HorschS.Intraoperative autotransfusion with a new disposable system. Ann Vasc Surg1986; 1:131–133.
4.
CliffordPC, KrugerAR, SmithA, ChantAD, WebsterJH.Salvage autotransfusion in aortic surgery: Initial studies using a disposable reservoir. Br J Surg1987; 74:755–757.
5.
BeesonPB.Jaundice occurring one to four months after transfusion of blood or plasma: report of seven cases. JAMA1943; 121:1332–1334.
6.
LeikolaJ.Transfusion transmitted infectious agents excluding hepatitis and human immunodeficiency viruses. Acta Anaesthesiol Scand1988; 32:20–25.
7.
Federal Centre for AIDS, Health and Welfare Canada.AIDS surveillance in Canada. Can Dis Wkly Rep1991; 17:5–9.
8.
SazamaK.Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion1990; 30:583–590.
9.
SilvaR, MooreEE, Bar-OrD, GallowayWB, WrightED.The risk:benefit of autotransfusion: Comparison to banked blood in a canine model. J Trauma1984; 24:557–564.
10.
McShaneAJ, PowerC, JacksonJF et al. Autotransfusion: Quality of blood prepared with a red cell processing device. Br J Anaesth1987; 59:1035–1039.
11.
BennettSH, GeelhoedGW, GralwickHR, HoyceRC.Effects of autotransfusion on blood elements. Am J Surg1973; 125:73–279.
12.
HauerJM, ThurerRL.Controversies in autotransfusion. Vox Sanguinis1984; 46:8–12.
13.
GriffithLD, BillmannGF, DailyPO, LaneTA.Apparent coagulopathy caused by infusion of shed mediastinal blood and its prevention by washing of the infusate. Ann Thorac Surg1989; 47:400–406.
14.
BengtsonJP, BackmanL, StenqvistO, HeidemanM, BengtssonA.Complement activation and reinfusion of wound drainage blood. Anesthesiology1990; 73:376–380.
15.
WodaR, TetzlaffJE.Upper airway oedema following autologous blood transfusion from a wound drainage system. Can J Anaesth1992; 39:290–292.
16.
Emergency Care Research Institute.Hemolysis and renal dysfunction associated with autotransfusion. Health Devices1990; 19:25–26.
17.
BrettonP, ReinesHD, SadeRM.Air embolization during autotransfusion for abdominal trauma. J Trauma1985; 25:165–166.
18.
YawnDH.Autologous blood salvage during elective surgery. Transfusion Science1989; 10:107–116.
19.
ArnestadJP, BengtssonA, BengtsonJP et al. Isolated hyperthermic liver perfusion with cytostatic containing perfusate activates the complement cascade. Br J Surg1992; 79:948–951.
20.
CavarocchiNC, PluthJR, SchaffHV et al. Complement activation during cardiopulmonary bypass: Comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg1986; 91:252–258.
21.
HakimRM, BreillattJ, LazarusJM, PortFK.Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med1984; 311:878–882.
22.
ButlerJ, PillaiR, RockerGM, WestabyS, ParkerD, ShaleDJ.Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg1993; 105:25–31.
23.
Haeffner-CavaillonN, CavaillonJM, CiancioniC, BacleF, DelonsS, KazatchkineMD.In vivo induction of interleukin-1 during hemodialysis. Kidney Int1989; 35:1212–1218.
24.
BorghiB, De SimoneN, BugamelliS, CaroliGC.Monitoring of intra and post-operative losses in orthopedic surgery. National Conference “Monitoring During Anaesthesia and Intensive Therapy”, Modena, Italy. 1991;1–4.
25.
MollnesTE, LeaT, FrolandSS, HarboeM.Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol1985; 22:197–202.
26.
DreherM, GunzerG, HelgerR, LangH.An automated homogeneous enzyme immunoassay for human PMN elastase. Prog Clin Biol Res1989; 308:707–710.
27.
FinkPC, Suin de BoutemardC, HaeckelR.Measurement of leukocyte elastase/alpha 1 proteinase-inhibitor complex using a homogeneous and a heterogeneous enzyme-immunoassay. J Clin Chem Clin Biochem1984; 22:869–871.
Muller-EberhardHJ.The membrane attack complex of complement. Ann Rev Immunol1986; 4:503–528.
30.
HughTE.Complement anaphylatoxins as plasma mediators, spasmogens and chemotaxins. In: BingDH, ed. The Chemistry and Physiology of Human Plasma Proteins. Pergamon Press, New York, 1979; 255–280.
31.
WebsterRO, HongSR, JohnstonRBJr, HensonPM.Biological effects of the human complement fragments C5a and C5adesArg on neutrophil function. Immunopharmac1980; 2:201–219.
32.
CavaillonJM, FittingC, Haeffner-CavallonN.Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol1990; 20:253–257.
33.
ScholzW, McClurgMR.Cardenas GJ et al. C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol1990; 57:297–307.
34.
RedlH, SchlagG, BahramiS, DaviesJ, JochumM, BengtssonA.Experimental and clinical evidence of leukocyte activation in trauma and sepsis. In: LevinJ, van DeventerSJH, van der PollT, SturkA, eds. Bacterial Endotoxins: Basic Science to Anti-Sepsis Strategies. Wiley-Liss Inc, New York1994; 221–245.
35.
ClementsDH, SculcoTP, BurkeS, MayerK, LevineDB.Salvage and reinfusion of postoperative sanguinous wound drainage. A preliminary report. J Bone Joint Surg1992; 74–A:646–651.
36.
FarisPM, RitterMA, KeatingEM, ValerCR.Unwashed filtered shed blood after knee and hip arthroplasties. J Bone Joint Surg1991; 73–A:1169–1178.
37.
StackG, SnyderEL.Cytokine generation in stored platelet concentrates. Transfusion1994; 34:20–25.
38.
MuylleL, WoutersE, De BockR, PeetermansME.Increased tumor necrosis factor α (TNF α), interleukin 1 (IL-1), and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF α and IL-6 levels and febrile transfusion reactions. Transfusion1993; 33:195–199.
39.
BlevinsFT, ShawB, ValeriR, KasserJ, HallJ.Reinfusion of shed blood after orthopaedic procedures in children and adolescents. J Bone Joint Surg1993; 75:363–371.
40.
FaquinWC, SchneiderTJ, GoldbergMA.Regulation of erythropoietin production by inflammatory cytokines: possible role in the pathogenesis of the anemia chronic disease. Blood1992; 79:1987–1994.
41.
SieunarineK, LangtonS, Lawrence-BrownMMD, GoodmanMA, PrendergastFJ, HellingsM.Elastase levels in salvaged blood and the effect of cell washing. Aust NZ J Surg1990; 60:613–616.
42.
BengtssonA, LisanderB.Anaphylatoxin and terminal complement complex in red cell salvage. Acta Anaesthesiol Scand1990; 34:339–341.
43.
ArnestadJP, BengtsonJP, BengtssonA, JohanssonS, RedlH, SchlagG.Release of cytokines, PMN elastase and terminal C5b-9 complement complex by reinfusion of wound drainage blood. Acta Ortopedica Scand1995; 66:334–338.
44.
HyllnerM, ArnestadJP, BengtsonJP, RydbergL, BengtssonA.Complement and leukocyte activation by storage of whole blood, erythrocyte concentrate and plasma. Acta Anesthesiol Scand, submitted for publication.
